Atlas Venture
Early-stage venture firm focused on creating and building biotechnology companies. Atlas uses a seed-led model, incubator/co-founding activity, and a long-term partnership approach to translate scientific innovation into medicines. The firm emphasizes a science-first, patient-centric culture and has operated for over 30 years.
Atlas Venture
Cambridge, Massachusetts, United States, North America
Services
Seed-led investments and incubator/co-founder activity
Primary investment approach is seed-led sourcing and company creation; the firm also incubates and co-founds companies to advance early-stage science toward de-risking and initial development.
Follow-on capital and long-term partnership
Provides guidance, resources and capital across multiple stages as companies progress from discovery to commercialization.
Operational resources and playbooks (Compass)
Digital resource (Compass) that contains guides, vendor lists and templates organized by department to support operational scaling of portfolio companies.
Peer community and knowledge sharing (Nautilus)
Exclusive online community for Atlas portfolio company leaders to share experiences, program topics and content driven by portfolio leadership.
Investor reporting and LP portals
Dedicated investor reporting portals for limited partners of current and legacy funds, providing access to financial statements, capital call/distribution notices and tax documents.
Seed-led investments and incubator/co-founder activity
Primary investment approach is seed-led sourcing and company creation; the firm also incubates and co-founds companies to advance early-stage science toward de-risking and initial development.
Follow-on capital and long-term partnership
Provides guidance, resources and capital across multiple stages as companies progress from discovery to commercialization.
Operational resources and playbooks (Compass)
Digital resource (Compass) that contains guides, vendor lists and templates organized by department to support operational scaling of portfolio companies.
Peer community and knowledge sharing (Nautilus)
Exclusive online community for Atlas portfolio company leaders to share experiences, program topics and content driven by portfolio leadership.
Investor reporting and LP portals
Dedicated investor reporting portals for limited partners of current and legacy funds, providing access to financial statements, capital call/distribution notices and tax documents.
Portfolio
Next-generation gene therapies enabling delivery of large genes.
#Gene therapy; delivery for large genes
Targets RNA-modifying proteins for precision cancer therapies.
#RNA-modifying proteins; precision oncology
Restoring metabolic balance to treat NASH; NASDAQ: AKRO (2019).
#Metabolic disease; NASH
Developing first-in-class precision medicines for cancer and other diseases.
#Precision medicines for cancer
Next-generation gene therapies enabling delivery of large genes.
#Gene therapy; delivery for large genes
Targets RNA-modifying proteins for precision cancer therapies.
#RNA-modifying proteins; precision oncology
Restoring metabolic balance to treat NASH; NASDAQ: AKRO (2019).
#Metabolic disease; NASH
Developing first-in-class precision medicines for cancer and other diseases.
#Precision medicines for cancer